We have investigated the inhibitory potential of prostaglandin E2 (PGE2) with respect to intracellular messengers implicated in the signaling system of T-lymphocyte activation pathway. Using the fluorescent indicator Quin 2, it is demonstrated that PGE2 inhibits the increase in cytosolic-free calcium concentration ICa211. Reconstitution of calcium mobilization in the presence of PGE2 by the calcium ionophore A23187 results in a partial restoration of both interleukin 2 (IL2) production and cell proliferation and has no effect on the inhibition of transferrin receptor expression. In contrast, the treatment of cell cultures with the tumor promotor 12.0 tetra decanoyl phorbol-13-acetate (TPA) abrogates the suppressor activity of PGE2. When T lymphocyte stimulation is provided by the combination of A23187 and TPA, the PGE2 inhibitory effect does not occur. These data also indicate that the down regulation of transferrin receptor by PGE2 is proximal to protein kinase C activation and is not associated with decreased expression of the functional IL2 receptor.
Introduction
Prostaglandin E2 (PGE2)1 is a potent chemical transmitter of intercellular and intracellular signals that mediate a diversity of physiologic and pathologic cell functions (1) . Several studies have revealed that PGE2 at physiologic concentrations induces a profound inhibition of T-lymphocyte activation and proliferation after in vitro stimulation with phytohemagglutinin (PHA) (2, 3). This inhibition has been shown to be associated with a parallel increase in intracellular levels of cyclic adenosine monophosphate (cAMP) (4) but the relationship of this cyclic nucleotide and the molecular events involved in the cellular activation process is still poorly understood.
We have previously demonstrated that PGE2 and increased intracellular concentrations of cAMP inhibit the production and secretion of the lymphocytotropic growth regulating peptide in- 1 . Abbreviations used in this paper: CT, cholera toxin; CTLL, cytotoxic T lymphocytes; ISO, isoproterenol; kd, dissociation constant; PGE2, prostaglandin E2; PGF2a, prostaglandin F2a; PHA, phytohemagutinin; PKC, protein kinase C; TPA, tetra decanoyl phorbol-1 3-acetate.
terleukin 2 (IL2), and the signal for proliferation provided by the expression oftransferrin receptor (5, 6) . In the murine system, it was reported that PGE2 down regulates la antigens on antigenpresenting cells (7, 8) .
Ligand binding to its specific membrane receptor results in the generation of a signal that is transmitted across the plasma membrane. This interaction promotes a rapid turnover ofphospholipids in lymphocyte membranes. The enhanced turnover is related to early events that trigger cellular activation including elevation of intracellular-free calcium [Ca2(]i and phosphorylation of cytoplasmic and nuclear proteins that trigger the lymphokine cascade and the sequential gene expression ofactivation antigens. Several lines of evidence support the concept that increase in [Ca2+1i is an essential activation signal toward the commitment ofcells to DNA synthesis (9, 10) . [Ca(2]i simultaneously results from the stimulated influx across the plasma membrane as well as the release from intracellular stores most likely from the endoplasmic reticulum. Protein kinase C (PKC) a Ca2' and phospholipid-dependent enzyme, has also been identified as an intracellular signaling system in T-lymphocyte activation. This enzyme is selectively activated by diacylglycerol (1 1), but can also be stimulated in vitro by its structural analogue, the tumorpromotor phorbol ester 12.0 tetradecanoyl-phorbol 13 acetate (TPA) (12) . PKC activation appears to act synergistically with increases in [Ca2+1i to mediate the responses to extracellular ligands (13, 14) . Recently, it has been reported that IL2-receptor interaction with IL2 stimulates a rapid and transient redistribution of PKC from the cytosol to the plasma membrane and that TPA induces PKC transposition in an analogous manner (15) .
In the present study we have investigated the regulatory effect ofPGE2 on T cell activation with respect to calcium mobilization and activation of PKC. Our results indicate that the PGE2 immunosuppressive effect on T cell activation involves predominantly PKC and support the involvement of PGE2 in the modulation of this enzymatic activation pathway.
Methods
Peripheral blood mononuclear leukocytes (PBL) Experiments described in this study were performed with enriched T cells in order to decrease endogenous PGE production by either B cells or excess contaminating number of monocytes. It was previously shown that this method for T cell enrichment provides a cell preparation in which monocyte-derived PGE2 has a minimal effect on T cells, while retaining sufficient monocytes for induction of mitogen activation (5, 15) . The PGE synthetase inhibitor, indomethacin, could not be used in these experiments since this drug is not a specific PG synthetase inhibitor and has actions other than on PG synthesis (i.e., inhibition of cAMPdependent protein kinase and blocking of active uptake of PGE2 in cells) (18) .
T lymphocyte proliferation assay. Enriched Richmond, CA). The tubes were spun 2 min at 12,000 rpm in the Beckman 12 microfuge. The tips of the tubes containing the cell pellet were cut off and transferred to counting vials. The 25I-IL2 was determined using a gamma counter (Quatro, LKB Instruments, Gaithersburg, MD). The cell pellet containing the 3H-anti Tac was resuspended with 200 Ml PBS in 20-ml glass scintillation vials followed by solubilization of the cells with 200 Ml 1% sodium dodecyl sulfate (SDS) and addition of 10 ml scintillation fluid. All results were adjusted for counting efficiency (78% for bound and free 25I; 45 and 39% for bound and free 3H, respectively).
The specific activity of the '251-IL2 was 7.5 X I05 dpm/pmol and its initial concentration in the assay was 200 pM. The specific activity of the 3H-anti Tac was 8.3 X 10' dpm/pmol and its initial concentration in the assay was 4 nM. Indirect immunofluorescent staining of cells and analysis with the fluorescence activated cell sorter. Indirect immunofluorescence was performed by incubating 1 X 10' cells with the monoclonal antibodies at the appropriate dilution for 30 min at 4°C, washing three times in phosphate-buffered saline (PBS) with 1% BSA and 0.02% sodium azide (PBS-BSA-azide). The cells were then incubated with a 1/40 dilution ofaffinitypurified goat anti-mouse IgG, F(ab`)2 fluoroisothiocyanate (FITC) (Cappel Laboratories, Cochranville, PA) for an additional 30 min at 4°C. After extensive washing in the PBS-BSA-azide buffer, cells were resuspended in l-ml PBS and examined using a fluorescence-activated cell sorter (EPICS-C, Coulter Electronics, Hialeah, FL).
Fluorescence datawerecollected on 1 X 10' viable cells, asdetermined by forward light scatter intensity. Background fluorescence was determined by using diluted normal mouse serum instead of monoclonal antibody. Percentage of stained cells was obtained from computed histograms.
Reagents. PHA (purified HA 16/17) was obtained from Wellcome Research Laboratories, Beckenham, England. PGE2 and prostaglandin F2a (PGF2a) purchased from Upjohn Co. (Kalamazoo, MI) were dissolved in 95% ethanol at a concentration of 10 mg/ml and stored at -70°C. Final ethanol concentrations in the culture did not exceed 0.1% and had no effect on the cell cultures. Dibutyryl cAMP (dBcAMP), cholera toxin (CT), TPA, and isoprotenerol (ISO), were obtained from Sigma Chemical Co. A23187 was purchased from Boehringer Mannheim, GmbH, FRG); and Quin 2 AM from (Calbiochem Behring Corp., La Jolla, CA). Culture medium was used for all dilutions.
Monoclonal antibodies. Monoclonal anti-Tac antibody was kindly supplied by Dr. W. C. Greene, National Cancer Institute. Anti-Tac reacts with human IL2 receptor on activated T cells (23). OKT9, which detects the human transferrin receptor (24) (3, 5, 6) . Fig. 1 A shows that addition of TPA at a concentration which by itself does not stimulate resting T cells (2.5 ,ug/ml) to the culture can overcome the PGE2-induced inhibitory effect on Tlymphocyte proliferation, suggesting a probable interference of PGE2 with PKC activation. Although addition ofTPA to a PHAstimulated culture in the presence ofPGE2 elicits full restoration of thymidine incorporation, it only partially restores the level of IL2 production in PGE2-treated cultures compared with the normal level obtained in untreated cultures (Fig. 1 B) .
Effect ofPGE2 onfree-cytoplasmic Ca . Mitogen-stimulated intracellular-free calcium increase, is well documented as a trigger for the intracellular activation process in T lymphocytes (9, 10 PGF2a had no effect on this parameter confirming the specific effect of PGE2 (data not shown). Effects of calcium ionophore A23187 on PGErtreated T lymphocytes. If the major mechanism by which PGE2 inhibits IL2 production and cell proliferation by T cells is mediated via an alteration ofcalcium mobilization, it would be expected that calcium influx induced by the calcium ionophore A23 187 would A ProIflratWv Resonse restore these events to normal. A23187 was utilized at a concentration that is not mitogenic (100 ng/ml), but which leads to increase in [Ca2+]i (data not shown). A23187 was added to PHAactivated T-cells in the presence or absence of varying concentrations ofPGE2. The results summarized in Fig. 3 demonstrate that cell proliferation measured by thymidine incorporation (Fig.  3 A) and IL2 production ( Fig. 3 B) of PHA-stimulated T cells were only partially restored after addition of A23187 in PGEr treated cultures. It is also shown that partial restoration of the proliferative response parallels the partial restoration ofIL2 production. These data suggest that PGE2 may exert its regulatory activity, at least in part, by interfering with calcium mobilization but do not support an exclusive role for Ca' in the inhibitory effect of this compound. Abrogation ofPGE2 inhibitory effect upon A23187 and TPA costimulation on PGErtreated Tlymphocytes. It is demonstrated in Table II that when PHA is used as a mitogen, PGE2 inhibits the IL2 production and the subsequent T cell proliferation in a concentration-dependent way. However, under conditions where stimulation of T lymphocytes is provided by the combination of TPA (2.5 ng/ml) and A23187 (100 ng/ml), proliferation is not blocked by PGE2 at concentrations that did effectively inhibit the PHA-induced T cell proliferative response. Since these cells escape the immunosuppressive effect of PGE2 the results would cultures were: medium alone (520 cpm) and medium plus A23187 (1,300 cpm).
suggest that PGE2 interferes with the endogenous T cell activation pathway involving both ofthe common transmembrane signals:
Ca2+ mobilization and PKC activation.
Differential effects ofTPA andA23187 on transferrin receptor expression by PGErtreated T-lymphocytes. One mechanism by which PGE2 modulates T cell proliferation is by inducing a down regulation of the transferrin receptor expression in PHA-stimulated culture (6) . We, therefore, examined ifCa2' mobilization and PKC activation are involved in this phenomenon.
As shown in Fig. 4 using OKT9 antibody for detection of the transferrin receptor, addition of PGE2 (10-7 M) to PHAstimulated culture induces a down regulation of transferrin receptor expression (67 vs. 28%). Addition of A23187 (100 ng/ ml) under those conditions has no effect on the expression of this receptor, which remains inhibited (72 vs. 34%). When TPA (2.5 ng/ml) was added to the culture a complete restoration of the expression oftransferrin receptor was achieved (84 vs. 78%). Moreover, the inhibitory effect of PGE2 on transferrin receptor expression observed when PHA is used as stimulator is not observed when the cellular activation is triggered by costimulation with A23187 and TPA (80 vs. 79%). These results are compatible with the concept that down regulation oftransferrin receptor by PGE2 involves modulation of PKC activity.
Effect of PGE2 upon high affinity IL2 binding. In earlier minished (data not shown). These data suggests that the suppressive effect of PGE2 on high affinity IL2 receptors is not the predominant cause for the down regulation of transferrin receptor and the inhibition of T cell proliferation. Antagonistic effects of TPA and cAMP elevating agents on
Tcell activation. The effects of PGE2 and cAMP elevating agents CT, and ISO on T cell proliferation and transferrin receptor expression were tested in the absence and in the presence of TPA at a concentration that by itselfhad no effect on lymphocyte activation. As shown in Table IV , in the absence of TPA, PGE2, CT, ISO, or dibutyryl cAMP inhibits T cell proliferation and transferrin receptor expression while PGF2 is found to have no regulatory effect. Under the same culture conditions, after addition of TPA (2.5 ng/ml) a complete loss of the inhibitory capacity of these pharmacologic agents with respect to thymidine incorporation and transferrin receptor expression is observed.
Discussion
In previous studies, we have demonstrated that PGE2 affects PHA-induced T-cell proliferation at least at two distinct levels: (10-v M) and tested with or without TPA (2.5 ng/ml).
tThymidine incorporation was performed as described in Fig. 2 .
Percentage of reactive cells after OKT9 monoclonal-antibody staining and FACS analysis determined as described in the legend to Fig. 4 . 11 Numbers in parentheses are percentages of response compared with the positive PHA-stimulated control culture (100%).
and IL2 production (Fig. 2) . A similar, partial restoration of PGE2 inhibition ofPHA-stimulated T cell proliferative response can be achieved by addition of exogenous IL2 (6 (10, 14) . Furthermore, it has been reported that IL2 binding to its receptor induce PKC transposition from the cytosol to the cell plasma membrane (15) . These observations, as well as our results, suggest that PGE2 exert additional effects on PKC activity beyond the effects mediated via [Ca2+]i.
While TPA completely restored mitogenic T cell proliferation of PGE2-treated cells, the IL2 activity in the culture supernatants, however, remained diminished. These seemingly contradictory observations can be explained if TPA at the concentration used was able to restore IL2 production to a level sufficient to induce a full proliferative response. Although IL2 is an essential requirement for T cell proliferation, it should be noted that the dose-response curve of T cell proliferation reaches a plateau at a finite IL2 concentration. It is also possible that in the presence of TPA, less IL2 is required to induce optimal T cell proliferation. Finally, TPA stimulation could involve an IL2-independent PKC-related proliferative pathway as has been suggested (32) .
It is in the present study demonstrated that PGE2 exerts a dual effect on PHA-induced T cell activation: alteration of [Ca2+] and inhibition of PKC activation pathway resulting in inhibition ofcell proliferation. If, however, the endogenous T cell activation pathway is triggered by costimulation with TPA and A23187, PGE2 has no effect on cell proliferation. This further reinforces the PGE2 involvement with the intracellular events regulating T cell activation following PHA stimulation.
Our studies also indicate that the mechanism that accounts for down regulation of transferrin receptor by PGE2 primarily involve the PKC-activation pathway. While TPA treatment of PHA-stimulated T lymphocytes in the presence ofPGE2 resulted in a restoration of normal expression of transferrin receptor, A23187 had no effect on this receptor. If, however, the stimulation was provided by the combination of TPA and A23 187, PGE2 had no inhibitory effect on transferrin receptor expression. Again, another essential event in PHA-induced T cell activation is controlled by PGE2.
It has been shown that the interaction ofIL2 with its receptors induce the expression of transferrin receptor (33) . As few as 100-200 molecules IL2 bound per cell is, however, sufficient to induce maximal T cell response (34) . Our studies demonstrate that PGE2 inhibit transferrin receptor expression as well as reduce the number ofhigh affinity IL2 receptors. However, the decrease in IL2 receptors is not sufficient to result in inhibition of cell proliferation. Furthermore, exogenous IL2 will restore only IL2 receptor expression and has no effect on transferrin receptor expression. In contrast, TPA will restore both IL2 receptor and transferrin receptor expression. These results suggest that IL2 and TPA activation have different regulatory effects on the in-duction of these receptors and that PGE2 does not affect the signaling pathway controlled by TPA. Modulation of PKC activity by PGE2 appears to involve cAMP. Our results clearly indicate that adenylate cyclase activators, in the presence of TPA, lose their inhibitory capacity on T cell proliferation and transferrin receptor expression. These data are in agreement with the concept that PHA-induced activation ofPKC might be controlled by cAMP through activation of PKA, which blocks the PKC activity (10) . It has also been reported that increased cAMP induce inhibition ofdiacylglycerol production, and thereby inhibition of PKC (14, 35) . However, in our system, addition of diacylglycerol did not abolish the effect of PGE2 (data not shown).
The mechanism by which PGE2 affects PKC activity and at which level of the enzyme activation process PGE2 operates are presently unknown. Our study would indicate that PGE2 could regulate the translocation of PKC from the cytosol to the cell membrane. Preliminary studies would suggest this mechanism (Piau, J. P., and S. Chouaib, unpublished observations). In contrast, TPA directly activates PKC, and thereby bypasses the effect of the second messenger generated following PHA stimulation. Our observations illustrate how biochemical defects in the signal transduction system correlate with phenotypic and functional abnormalities of T cell response and could explain why functional T cell defects occur in diseases associated with abnormal levels of PGE2 (37, 38) .
